Trial results are expected in the first half of 2022.
"Combination of these two vaccines ... may lead to greater efficiencies for the healthcare system and achieve high levels of protection against Covid-19 and influenza with a single regimen," Gregory Glenn, President of Research and Development at Novavax, said in a statement.
Novavax had said in May it expects seasonal influenza and Covid-19 combination vaccines to likely be critical in combating emerging Covid-19 variants. Its vaccine NanoFlu/NVX-CoV2373 had elicited robust responses to both influenza A and B and protected against the coronavirus in pre-clinical studies.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Novavax begins early-stage trial for combined influenza/COVID-19 vaccineVaccine developer Novavax Inc said on Wednesday it has initiated an early-stage study to test its combined flu and COVID-19 vaccine.
Weiterlesen »
Novavax begins early-stage trial for combined influenza/COVID-19 vaccineParticipants will receive a combination of the company's COVID-19 vaccine candidate, NVX-CoV2373, and its Influenza shot NanoFlu along with an adjuvant or vaccine booster. 'Combination of these two vaccines...may lead to greater efficiencies for the healthcare system and achieve high levels of protection against COVID-19 and influenza with a single regimen,' Gregory Glenn, President of Research and Development at Novavax, said in a statement. Novavax had said in May it expects seasonal influenza and COVID-19 combination vaccines to likely be critical in combating emerging COVID-19 variants.
Weiterlesen »
Novavax begins early-stage trial for combined flu/COVID-19 vaccineTrial results are expected in the first half of 2022.
Weiterlesen »
Fraud trial of Theranos founder Elizabeth Holmes set to beginTheranos founder Elizabeth Holmes goes on trial on Wednesday in federal court, with prosecutors poised to lay out fraud charges against the former Silicon Valley star accused of lying about her now-defunct blood-testing startup once valued at $9 billion.
Weiterlesen »
College-Admissions Scandal to See First Trial Next WeekThe case has highlighted how gaining entry to selective colleges amounts to a bruising competition in many affluent pockets of the U.S. and exposed how parts of the admission process have been ripe for exploitation.
Weiterlesen »
9/11 mastermind KSM's trial restarts days before the attack anniversaryMastermind behind the 9/11 attacks heads for trial as the years-old case drags on with defence lawyers arguing that Khalid Sheikh Mohammed and other accused men were tortured by CIA into confessing to the crime
Weiterlesen »